Survival Analysis Done Wisely
Survival analysis is one of the most useful and frequently implemented statistic tools in clinical trial analysis, especially in the oncology field. Although the name of this technique may seem to be linked to the analysis of patients’ survival, it is a very versatile technique! Keep reading if you want to learn more about the features and components of this analysis!
Bravo for diversity!
In the LGTBI pride week we want to state, once again, what defines us as an organization: at Sermes CRO we are a company with a soul, a company in which the human – and social – component have a main weight. When we say “bravo for diversity” it’s not just words. We are talking about facts. Do you want to know why?
Are we making the most of the new European clinical trials platform, CTIS?
We analyze the usage data of the CTIS in its first three months of operation and we present you the new report that the EMA will publish periodically with the main KPIs. It comprehensively monitors the European clinical trial ecosystem.
Clinical trials: the patient’s perspective
What are clinical trials? What is the point of clinical trials? Are they different from common clinical practice? Who is involved in clinical trials? From the beginning of the development of any drug until it is available to patients and health professionals, its safety and efficacy must be studied and demonstrated. That is exactly what clinical trials are conducted for!!
From data recording to changing people’s lives: 25 years of Sermes CRO
Today is a big day for Sermes CRO. We are celebrating our 25th anniversary!! Antonio Berlanga, our CEO, was one of the two people that founded the company back in 1997. We now have more than 250 employees and have managed mora than 1500 clinical trials during the last five years. Learn more about our history and our future reading the full article!
How to solve reimbursement to patients effectively
The lack of access of the clinical trial sponsors to the patients’ data is in line with the ethic that should govern any clinical research. Nevertheless, this rule can be a great obstacle when it comes to carrying out a reimbursement or payment to the patients. This is the reason of being of PayPat, a solution to the management of reimbursements towards patients, in which leading pharmaceutical laboratories already trust
Gene therapy, to be conjugated in the present tense
Gene therapy in humas is the transfer of genetic material to an individual with therapeutic purposes. The development of the gene therapy in the last 30 years has been a complicated path and full of challenges, accumulating a high number of negative results. Nevertheless, the advance in research and the development of new alternatives have made that currently gene therapy occupies a central position in the pharmaceutical market.
Conference in Madrid: “CTIS: full application of the European regulation of clinical trials”
The experts participating in our conference agreed to value the CTIS as a tool that will be very useful for the management of clinical trials in Europe, by harmonizing the requirements among different countries and centralizing documentation management
Sermes CRO, first company to manage the submission of a clinical trial in Spain through CTIS
Sermes CRO, together with Mikrobiomik, manages the first submission of a clinical trial in Spain through CTIS (Clinical Trial Information System), the new European clinical trial’s portal.
Coping with missing values in clinical trials
When it comes to clinical trial statistical analysis, missing values are a major challenge that we need to address. Have they ever been a problem for you? If so, or if you just want to learn more about them, keep on reading!
